RDO Pharm.: Clinical Trials

2 trials sponsored by RDO Pharm., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 31Completed 1

Follow RDO Pharm.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer
99mTc-3PRGD2 injection - Lung Cancer, Lymph Node Metastasis
Phase 3CompletedRDO Pharm.4092019-10-122024-07-01
A Study of 99mTc-3PRGD2 Injection in Healthy Volunteers
99mTc niacinamide polyethylene glycol bicyclic RGD peptide (99mTc-3PRGD2) - Healthy
Phase 1CompletedRDO Pharm.102018-12-122019-08-08

Conditions studied

Lung Neoplasms (1)  ·  Lymphatic Metastasis (1)

Interventions

Technetium (1)

Countries

China (2)

Top investigators

Zhaohui Zhu, MD, PhD (1)  ·  Zhaohui Zhu, professor (1)